POC detection of chlamydia and gonorrhea small RNAs using a target reporter construct assay by lateral flow in urine surrogates

Both chlamydia and gonorrhea can lead to serious health and reproductive issues and are well-known and established risk factors for human immunodeficiency virus (HIV) infection, and yet the number of cases in the U.S. has risen significantly since 2014.  These sexually transmitted diseases are often asymptomatic in many infected individuals and routine screening is strongly recommended by the Centers of Disease Control and Prevention (CDC) and the World Health Organization (WHO).  RedVault Biosciences is developing a low cost, rapid, and accurate POC assay for the detection of chlamydia and gonorrhea that could facilitate early detection, thus potentially reducing transmission and sequelae as well as improving therapeutic outcomes in the clinic.

© 2025 RedVault Biosciences.  All rights reserved.                                                                                                                          

Terms of use